What were the gross proceeds from Gregg Williams’ Vivani Medical (VANI) share purchases?

The filing states gross proceeds of $1,350,000.40 for the purchase of 1,310,680 shares at $1.03 per share, and $333,334.26 for the purchase of 264,551 shares at $1.26 per share. Both amounts relate to private sale transactions documented in Share Purchase Agreements.

Gregg Williams (VANI) adds over 1.5M Vivani Medical shares in private buys

Filing Impact

(Very High)

Filing Sentiment

(Positive)

Form Type

Rhea-AI Filing Summary

Vivani Medical director and 10% owner Gregg Williams reported significant open-market purchases of Vivani Medical, Inc. common stock. On two private sale transactions dated in Share Purchase Agreements on May 12, 2025 and August 11, 2025, he purchased 1,310,680 shares at $1.03 per share and 264,551 shares at $1.26 per share, respectively. The related footnotes state gross proceeds of $1,350,000.40 for the first transaction and $333,334.26 for the second. After these transactions, he directly and indirectly controls 36,156,383 shares, including 4,799,200 shares held directly and additional shares held through the Gregg G. Williams 2006 Trust, Williams International Co. LLC, Sam Williams Family Investments LLC, and the Sam B. Williams 1995 Generation-Skipping Trust, over which he has voting and dispositive power.

Insider Trade Summary

Net Buyer: 1,575,231 shares ($1,683,335)

Net Buy 3 txns

Insider Williams Gregg

Role Director, 10% Owner

Bought 1,575,231 shs ($1.68M)

Type	Security	Shares	Price	Value
Purchase	Common Stock	1,310,680	$1.03	$1.35M
Purchase	Common Stock	264,551	$1.26	$333K
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 31,092,632 shares (Indirect, See footnote); Common Stock — 4,799,200 shares (Direct)

Footnotes (1)

The reporting person purchased 1,310,680 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of May 12, 2025 at a price of $1.03 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on May 9, 2025 (three days immediately prior to May 12, 2025). The gross proceeds from this private sale transaction were $1,350,000.40. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person purchased 264,551 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $333,334.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote. The reporting person owns 36,156,383 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 29,231,431 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

Form 4 Insider Transactions: What Each Field Means →

03/16/2026 - 06:15 AM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Williams Gregg

(Last)

(First)

(Middle)

C/O VIVANI MEDICAL, INC.

1350 S. LOOP ROAD

(Street)

ALAMEDA

94502

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
Vivani Medical, Inc. [ VANI ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	X	10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
03/15/2026

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
Common Stock	03/15/2026		P⁽¹⁾		1,310,680	A	$1.03	31,092,632	I	See footnote⁽³⁾
Common Stock	03/15/2026		P⁽²⁾		264,551	A	$1.26	31,357,183	I	See footnote⁽³⁾
Common Stock								4,799,200	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)

Explanation of Responses:

1. The reporting person purchased 1,310,680 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of May 12, 2025 at a price of $1.03 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on May 9, 2025 (three days immediately prior to May 12, 2025). The gross proceeds from this private sale transaction were $1,350,000.40. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

2. The reporting person purchased 264,551 shares of the Issuer's common stock in a private sale transaction as disclosed in the Share Purchase Agreement dated as of August 11, 2025 at a price of $1.26 per share, which was the last reported sale price of the Issuer's common stock on the Nasdaq on August 10, 2025 (the day immediately prior to August 11, 2025). The gross proceeds from this private sale transaction were $333,334.26. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased in the transaction set forth in this footnote.

3. The reporting person owns 36,156,383 shares directly and/or indirectly as follows: (i) 4,799,200 shares of common stock owned by the reporting person, (ii) 29,231,431 shares of common stock owned by Gregg G. Williams 2006 Trust, (iii) 1,212,856 shares of common stock owned by Williams International Co. LLC, (iv) 181,587 shares of common stock owned by Sam Williams Family Investments LLC, and (v) 731,309 shares of common stock owned by Sam B. Williams 1995 Generation-Skipping Trust. Gregg Williams has voting and dispositive power over all of these shares.

	/s/ Anthony Baldor, Attorney-in-fact	03/16/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

Source: View Original Filing on SEC EDGAR

FAQ

What insider transaction did Gregg Williams report for Vivani Medical (VANI)?

Gregg Williams reported buying Vivani Medical common stock in two private sale transactions. He acquired 1,310,680 shares at $1.03 per share and 264,551 shares at $1.26 per share, both documented in Share Purchase Agreements dated May 12, 2025 and August 11, 2025.

How many Vivani Medical (VANI) shares did Gregg Williams buy in total?

In the reported transactions, Gregg Williams purchased two blocks of Vivani Medical common stock: 1,310,680 shares at $1.03 and 264,551 shares at $1.26. These purchases were made in private sale transactions under Share Purchase Agreements dated May 12, 2025 and August 11, 2025.

What prices did Gregg Williams pay for Vivani Medical (VANI) shares?

Gregg Williams paid $1.03 per share for 1,310,680 Vivani Medical shares and $1.26 per share for 264,551 shares. Footnotes state these prices matched the last reported Nasdaq sale prices on May 9, 2025 and August 10, 2025, respectively, immediately before the agreement dates.

How many Vivani Medical (VANI) shares does Gregg Williams control after these transactions?

After the reported transactions, Gregg Williams controls 36,156,383 Vivani Medical shares directly and indirectly. This includes 4,799,200 shares held directly and additional shares held through the Gregg G. Williams 2006 Trust, Williams International Co. LLC, Sam Williams Family Investments LLC, and the Sam B. Williams 1995 Generation-Skipping Trust.

Through which entities does Gregg Williams hold Vivani Medical (VANI) shares?

Gregg Williams holds Vivani Medical shares directly and via several entities: Gregg G. Williams 2006 Trust, Williams International Co. LLC, Sam Williams Family Investments LLC, and Sam B. Williams 1995 Generation-Skipping Trust. The filing states he has voting and dispositive power over all these shares.